Noah Capurso, MD, MHS. Assistant Medical Director, Connecticut Valley Hospital, Middletown, CT; Associate Clinical Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.
Dr. Capurso has no financial relationships with companies related to this material.
Heidi Moawad, MD. Clinical assistant professor, Case Western Reserve School of Medicine, Cleveland, OH.
Noah Capurso, MD, MHS. Assistant professor of psychiatry, Yale University, New Haven, CT; Editor-in-Chief, The Carlat Addiction Treatment Report.
Dr. Moawad and Dr. Capurso have no financial relationships with companies related to this material.
Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD, have no financial or other interests in any commercial companies pertaining to this educational activity.
Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD, have no financial or other interests in any commercial companies pertaining to this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
